Il y a eu 50 transactions d'initiés récentes enregistrées pour ESSA Pharma Inc. (EPIX), dont 18 achats et 31 ventes. Le total des achats d'initiés s'élève à $11.57M et le total des ventes d'initiés à $10.93M.
Les initiés notables ayant une activité récente comprennent Biotech Growth N V, Virsik Peter, Glickman Richard M. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — EPIX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-11-01 |
Biotech Growth N V |
10 Percent Owner |
Vente Informative |
1,879,583 |
$1.51 |
$2.84M |
- |
| 2024-09-09 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
694 |
$6.00 |
$4.16K |
8,470 |
| 2024-09-03 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
2,082 |
$6.03 |
$12.55K |
9,164 |
| 2024-05-06 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
694 |
$6.95 |
$4.82K |
11,246 |
| 2024-04-24 |
Glickman Richard M |
Director |
Exercice d'Options (Vente) |
3,750 |
$4.90 |
$18.38K |
- |
| 2024-04-05 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
694 |
$7.94 |
$5.51K |
11,940 |
| 2024-03-25 |
Zweifach Sanford S |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Berger Franklin M |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Glickman Richard M |
Director |
Attribution de RSU |
70,000 |
$9.04 |
$632.8K |
70,000 |
| 2024-03-25 |
Parkinson David Ross |
Chief Executive Officer |
Attribution de RSU |
350,000 |
$9.04 |
$3.16M |
350,000 |
| 2024-03-25 |
Martin John Alexander |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Requadt Scott |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Virsik Peter |
Chief Operating Officer |
Attribution de RSU |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Thorell Marella |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Sollis Gary |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Wood David S. |
Chief Financial Officer |
Attribution de RSU |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Cesano Alessandra |
Chief Medical Officer |
Attribution de RSU |
200,000 |
$9.04 |
$1.81M |
200,000 |
| 2024-03-25 |
Merendino Lauren |
Director |
Attribution de RSU |
25,000 |
$9.04 |
$226K |
25,000 |
| 2024-03-25 |
Kantoff Philip W. |
Director |
Attribution de RSU |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-05 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
694 |
$8.98 |
$6.23K |
12,634 |
| 2024-02-06 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
72,782 |
$10.29 |
$748.93K |
13,328 |
| 2024-02-05 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
500 |
$10.04 |
$5.02K |
13,328 |
| 2024-01-16 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
1,718 |
$10.01 |
$17.2K |
14,022 |
| 2024-01-05 |
Virsik Peter |
Chief Operating Officer |
Vente Informative |
699 |
$6.11 |
$4.27K |
14,022 |
| 2023-12-14 |
Parkinson David Ross |
Chief Executive Officer |
Achat Informatif |
9,223 |
$2.30 |
$21.21K |
65,675 |
| 2023-11-21 |
Berger Franklin M |
Director |
Achat Informatif |
23,259 |
$5.73 |
$133.27K |
784,404 |
| 2023-11-07 |
Parkinson David Ross |
Chief Executive Officer |
Cession |
171,470 |
$3.23 |
$553.85K |
- |
| 2023-11-07 |
Virsik Peter |
Chief Operating Officer |
Cession |
970,000 |
$3.23 |
$3.13M |
- |
| 2023-11-07 |
Wood David S. |
Chief Financial Officer |
Cession |
330,000 |
$3.23 |
$1.07M |
- |
| 2023-11-07 |
Cesano Alessandra |
Chief Medical Officer |
Cession |
400,000 |
$3.23 |
$1.29M |
- |
| 2023-11-06 |
Requadt Scott |
Director |
Autre (Vente) |
12,500 |
- |
- |
30,002 |
| 2023-11-04 |
Berger Franklin M |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Glickman Richard M |
Director |
Cession |
30,000 |
$3.23 |
$96.9K |
- |
| 2023-11-04 |
Clarus Lifesciences Iii, L.p. |
10 Percent Owner |
Inconnu |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Requadt Scott |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Brettman Ari David |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Thorell Marella |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Sollis Gary |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Zweifach Sanford S |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Martin John Alexander |
Director |
Cession |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-03 |
Berger Franklin M |
Director |
Achat Informatif |
16,471 |
$5.99 |
$98.66K |
760,875 |
| 2023-11-02 |
Berger Franklin M |
Director |
Achat Informatif |
60,000 |
$5.35 |
$321K |
744,404 |
| 2023-10-30 |
Requadt Scott |
Director |
Autre (Vente) |
17,502 |
- |
- |
42,502 |
| 2023-10-24 |
Wood David S. |
Chief Financial Officer |
Attribution de RSU |
3,750 |
$3.91 |
$14.66K |
3,750 |
| 2023-06-06 |
Merendino Lauren |
Director |
Cession |
50,000 |
$3.05 |
$152.5K |
- |
| 2023-03-08 |
Berger Franklin M |
Director |
Cession |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Glickman Richard M |
Director |
Cession |
10,000 |
$3.81 |
$38.1K |
- |
| 2023-03-08 |
Parkinson David Ross |
Chief Executive Officer |
Cession |
45,000 |
$3.81 |
$171.45K |
- |
| 2023-03-08 |
Requadt Scott |
Director |
Cession |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Virsik Peter |
Chief Operating Officer |
Cession |
40,000 |
$3.81 |
$152.4K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
